One question has relentlessly followed ChatGPT in its trajectory to superstar status in the field of artificial intelligence: Has it met the Turing test of generating output indistinguishable from human response?
ChatGPT may be smart, quick and impressive. It does a good job at exhibiting apparent intelligence. It sounds humanlike in conversations with people and can even display humor, emulate the phraseology of teenagers, and pass exams for law school.
But on occasion, it has been found to serve up totally false information. It hallucinates. It does not reflect on its own output.
Cameron Jones, who specializes in language, semantics and machine learning, and Benjamin Bergen, professor of cognitive science, drew upon the work of Alan Turing, who 70 years ago devised a process to determine whether a machine could reach a point of intelligence and conversational prowess at which it could fool someone into thinking it was human.
Their report titled “Does GPT-4 Pass the Turing Test?” is available on the arXiv preprint server.
They rounded up 650 participants and generated 1,400 “games” in which brief conversations were conducted between participants and either another human or a GPT model. Participants were asked to determine who they were conversing with.
The researchers found that GPT-4 models fooled participants 41% of the time, while GPT-3.5 fooled them only 5% to 14% of the time. Interestingly, humans succeeded in convincing participants they were not machines in only 63% of the trials.
The researchers concluded, “We do not find evidence that GPT-4 passes the Turing Test.”
They noted, however, that the Turing test still retains value as a measure of the effectiveness of machine dialogue.
“The test has ongoing relevance as a framework to measure fluent social interaction and deception, and for understanding human strategies to adapt to these devices,” they said.
They warned that in many instances, chatbots can still communicate convincingly enough to fool users in many instances.
“A success rate of 41% suggests that deception by AI models may already be likely, especially in contexts where human interlocutors are less alert to the possibility they are not speaking to a human,” they said. “AI models that can robustly impersonate people could have could have widespread social and economic consequences.”
The researchers observed that participants making correct identifications focused on several factors.
Models that were too formal or too informal raised red flags for participants. If they were too wordy or too brief, if their grammar or use of punctuation was exceptionally good or “unconvincingly” bad, their usage became key factors in determining whether participants were dealing with humans or machines.
Test takers also were sensitive to generic-sounding responses.
“LLMs learn to produce highly likely completions and are fine-tuned to avoid controversial opinions. These processes might encourage generic responses that are typical overall, but lack the idiosyncrasy typical of an individual: a sort of ecological fallacy,” the researchers said.
The researchers have suggested that it will be important to track AI models as they gain more fluidity and absorb more humanlike quirks in conversation.
“It will become increasingly important to identify factors that lead to deception and strategies to mitigate it,” they said.
News
Scientists Have Uncovered Previously Hidden Microbial Activity on Human Skin
The most abundant microbes on your skin may not be the ones doing most of the work. Human skin supports vast communities of bacteria, fungi, and viruses that can influence its protective barrier, immune [...]
Brazilian Tree Compounds Fight COVID-19 on Multiple Fronts
Scientists found compounds in a Brazilian tree that hit SARS-CoV-2 on multiple fronts, revealing a promising new lead in the search for COVID-19 treatments. Researchers have found that galloylquinic acids extracted from the leaves [...]
Cutting Two Amino Acids Slowed Prostate Cancer in Mice
A newly identified link between amino acid metabolism and cholesterol production may help prostate tumors adapt to hormone therapy. Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they [...]
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]















